Genetic alterations of PTEN in human melanoma

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• The PTEN gene is a frequently inactivated tumor suppressor gene in sporadic cancers.
• PTEN alterations are observed in various cancers, including melanoma, but their precise frequency in melanoma is not well-established.
• Understanding PTEN's role is critical for melanoma research and therapeutic development.

Purpose of the Study:

• To comprehensively review and quantify the frequency of PTEN genetic alterations in melanoma.
• To identify mutation hotspots and types of PTEN alterations in melanoma cell lines and tumor biopsies.
• To explore the implications of PTEN mutations for melanoma pathogenesis and potential therapeutic strategies.

Main Methods:

• Systematic literature review of 16 studies focusing on PTEN genetic alterations in melanoma.
• Analysis of reported PTEN alterations in melanoma cell lines and tumor biopsies (primary and metastatic).
• Identification and characterization of specific PTEN mutations and deletions.

Main Results:

• A total of 76 PTEN alterations were reported in melanoma cell lines and 38 in melanoma biopsies.
• PTEN alteration rates were 27.6% in cell lines, 7.3% in primary melanoma, and 15.2% in metastatic melanoma.
• A mutational hotspot was identified in exon 5, encoding the phosphatase activity domain; mutations were scattered, avoiding exon 9.

Conclusions:

• PTEN alterations are common in melanoma, varying by disease stage and sample type.
• The identified mutational hotspot in exon 5 suggests functional importance.
• Further research into PTEN function and its mutations may reveal new therapeutic targets for melanoma.